Association of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imaging
- 15 May 2009
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 23 (8) , 941-949
Abstract
Background: HIV-infected individuals may be at increased risk for atherosclerosis. Although this is partially attributable to metabolic factors, HIV-associated inflammation may play a role. Objective: To investigate associations of HIV disease with serum monocyte chemoattractant protein-1/chemokine (C–C motif) ligand 2 (MCP-1/CCL2) levels and atherosclerosis burden. Design: A cross-sectional analysis. Methods: Serum MCP-1/CCL2, fasting lipids, and glucose tolerance were measured in 98 HIV-infected and 79 demographically similar uninfected adults. Eighty-four participants had MRI of the carotid arteries and thoracic aorta to measure atherosclerosis burden. Multivariate analyses were performed using linear regression. Results: Mean MCP-1/CCL2 levels did not differ between HIV-infected and uninfected participants (P = 0.65). Among HIV-infected participants, after adjusting for age, BMI, and cigarette smoking, HIV-1 viral load was positively associated with MCP-1/CCL2 (P = 0.02). Multivariate analyses adjusting for sex, low-density lipoprotein cholesterol, total cholesterol:high-density lipoprotein cholesterol ratio, cigarette smoking, MCP-1/CCL2, and protease inhibitor use found that HIV infection was associated with greater mean thoracic aorta vessel wall area (VWA, P < 0.01) and vessel wall thickness (VWT, P = 0.03), but not with carotid artery parameters. Compared with being uninfected, having detectable HIV-1 viremia was associated with greater mean thoracic aorta VWA (P < 0.01) and VWT (P = 0.03), whereas being HIV-infected with undetectable viral load was associated with greater thoracic aorta VWA (P = 0.02) but not VWT (P = 0.15). There was an independent positive association of MCP-1/CCL2 with thoracic aorta VWA (P = 0.01) and VWT (P = 0.01). Conclusion: HIV-1 viral burden is associated with higher serum levels of MCP-1/CCL2 and with atherosclerosis burden, as assessed by thoracic aorta VWA and VWT.Keywords
This publication has 31 references indexed in Scilit:
- The Reliability of High Resolution MRI in the Measurement of Early Stage Carotid Wall ThickeningJournal of Cardiovascular Magnetic Resonance, 2007
- Class of Antiretroviral Drugs and the Risk of Myocardial InfarctionNew England Journal of Medicine, 2007
- HIV and Cardiovascular Disease: Contribution of HIV-Infected Macrophages to Development of AtherosclerosisPLOS Medicine, 2007
- Carotid Intimal Medial Thickness in Human Immunodeficiency Virus-Infected Women: Effects of Protease Inhibitor Use, Cardiac Risk Factors, and the Metabolic SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2006
- Androgen Levels in Older Men Who Have or Who Are at Risk of Acquiring HIV InfectionClinical Infectious Diseases, 2005
- Atherosclerosis in Patients Infected With HIV Is Influenced by a Mutant Monocyte Chemoattractant Protein-1 AlleleCirculation, 2004
- Exposure to fluid shear stress modulates the ability of endothelial cells to recruit neutrophils in response to tumor necrosis factor-α: a basis for local variations in vascular sensitivity to inflammationBlood, 2003
- Human Vascular Smooth Muscle Cells Possess Functional CCR5Journal of Biological Chemistry, 2000
- Chemokine Receptor CCR2 Expression and Monocyte Chemoattractant Protein-1–Mediated Chemotaxis in Human MonocytesArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Plasma Levels of Monocyte Chemoattractant Protein‐1 but Not Those of Macrophage Inhibitory Protein‐1a and RANTES Correlate with Virus Load in Human Immunodeficiency Virus InfectionThe Journal of Infectious Diseases, 1997